ITGAM and neoplasm: As shown in Fig. 6, the number of MHC IIhi (M1-like) TAMs was increased in LLC tumors co-injected with Cav-2 KO bone marrow cells relative to both CD11b+F4/80+ TAM populations (Fig. 6C; left panel) and to total cells in tumor (Fig. 6D; left panel).